Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 1
2012 4
2013 4
2014 3
2015 4
2016 1
2017 1
2018 4
2019 1
2020 1
2021 2
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Multi-omic approach identifies hypoxic tumor-associated myeloid cells that drive immunobiology of high-risk pediatric ependymoma.
Griesinger AM, Riemondy K, Eswaran N, Donson AM, Willard N, Prince EW, Paine SML, Bowes G, Rheaume J, Chapman RJ, Ramage J, Jackson A, Grundy RG, Foreman NK, Ritzmann TA. Griesinger AM, et al. Among authors: paine sml. iScience. 2023 Aug 9;26(9):107585. doi: 10.1016/j.isci.2023.107585. eCollection 2023 Sep 15. iScience. 2023. PMID: 37694144 Free PMC article.
Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
Chapman RJ, Ghasemi DR, Andreiuolo F, Zschernack V, Espariat AT, Buttarelli FR, Giangaspero F, Grill J, Haberler C, Paine SML, Scott I, Jacques TS, Sill M, Pfister S, Kilday JP, Leblond P, Massimino M, Witt H, Modena P, Varlet P, Pietsch T, Grundy RG, Pajtler KW, Ritzmann TA. Chapman RJ, et al. Among authors: paine sml. Neuro Oncol. 2023 Oct 3;25(10):1871-1882. doi: 10.1093/neuonc/noad055. Neuro Oncol. 2023. PMID: 36916248 Free PMC article.
SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort-A BIOMECA Consortium Study.
Ritzmann TA, Chapman RJ, Kilday JP, Thorp N, Modena P, Dineen RA, Macarthur D, Mallucci C, Jaspan T, Pajtler KW, Giagnacovo M, Jacques TS, Paine SML, Ellison DW, Bouffet E, Grundy RG. Ritzmann TA, et al. Among authors: paine sml. Neuro Oncol. 2022 Jun 1;24(6):936-948. doi: 10.1093/neuonc/noac012. Neuro Oncol. 2022. PMID: 35018471 Free PMC article. Clinical Trial.
A case series of Diffuse Glioneuronal Tumours with Oligodendroglioma-like features and Nuclear Clusters (DGONC).
Pickles JC, Mankad K, Aizpurua M, Paine SM, Bridges LR, Carceller F, Szychot E, Walker M, Fairchild AR, Mistry T, Ogunbiyi O, Rolland A, Stone TJ, Dryden C, Addy D, Garimberti E, Chalker J, Sahm F, Jones DT, Hargrave D, Jacques TS. Pickles JC, et al. Among authors: paine sm. Neuropathol Appl Neurobiol. 2021 Apr;47(3):464-467. doi: 10.1111/nan.12680. Epub 2021 Jan 12. Neuropathol Appl Neurobiol. 2021. PMID: 33325069 Free PMC article.
Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours.
Bennett CD, Kohe SE, Gill SK, Davies NP, Wilson M, Storer LCD, Ritzmann T, Paine SML, Scott IS, Nicklaus-Wollenteit I, Tennant DA, Grundy RG, Peet AC. Bennett CD, et al. Among authors: paine sml. Sci Rep. 2018 Aug 10;8(1):11992. doi: 10.1038/s41598-018-30342-8. Sci Rep. 2018. PMID: 30097636 Free PMC article.
The neuropathological consequences of CDKL5 mutation.
Paine SM, Munot P, Carmichael J, Das K, Weber MA, Prabhakar P, Jacques TS. Paine SM, et al. Neuropathol Appl Neurobiol. 2012 Dec;38(7):744-7. doi: 10.1111/j.1365-2990.2012.01292.x. Neuropathol Appl Neurobiol. 2012. PMID: 22812903 No abstract available.
31 results